Verrica Pharmaceuticals Engages Investors at Upcoming Event
![Verrica Pharmaceuticals Engages Investors at Upcoming Event](https://investorshangout.com/images/blog/ihnews-Verrica%20Pharmaceuticals%20Engages%20Investors%20at%20Upcoming%20Event.jpg)
Verrica Pharmaceuticals Engages Investors at Upcoming Event
Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), based in West Chester, is a notable player in dermatology therapeutics, focusing on innovative treatments for skin diseases that need medical intervention. The Company recently announced that Ted White, the President and CEO, will participate in a compelling fireside chat at the esteemed H.C. Wainwright 26th Annual Global Investment Conference in New York City.
Details of the Investment Conference
This year's H.C. Wainwright 26th Annual Global Investment Conference will be held from September 9-11, and is anticipated to gather leading investors and analysts within the healthcare sector.
Event Information:
Date: Monday, September 9
Time: 1:30 PM ET
Location: New York, NY
Accessing the Live Webcast
Investors can tune into a live webcast of the event which can be accessed through the company's official website. The presentation will also be available for replay shortly after the event, ensuring that those unable to attend can still access important insights shared by Mr. White.
Verrica’s Innovative Dermatology Solutions
Verrica Pharmaceuticals is on a mission to tackle significant unmet needs in dermatology. The Company’s flagship product, YCANTH (VP-102), is a groundbreaking treatment approved by the FDA for molluscum contagiosum, a common and highly contagious viral skin infection. This product primarily benefits children, influencing the lives of approximately 6 million individuals across the United States.
Future Developments for Verrica
In addition to YCANTH, Verrica is expanding its product pipeline with the development of VP-103, intended for the treatment of plantar warts. Furthermore, the Company has secured a worldwide license agreement with Lytix Biopharma AS for VP-315, targeting non-melanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma.
Company Contact Information
For more information regarding the company’s initiatives and developments, the following contacts are available:
Terry Kohler
Chief Financial Officer
Email: tkohler@verrica.com
Kevin Gardner
LifeSci Advisors
Email: kgardner@lifesciadvisors.com
Chris Calabrese
LifeSci Advisors
Email: ccalabrese@lifesciadvisors.com
Frequently Asked Questions
What is Verrica Pharmaceuticals known for?
Verrica Pharmaceuticals specializes in dermatology therapeutics, developing treatments for skin diseases that require medical interventions.
Who will represent Verrica at the H.C. Wainwright conference?
Ted White, the President and Chief Executive Officer, will participate in a fireside chat at the event.
When is the H.C. Wainwright 26th Annual Global Investment Conference?
The conference will take place from September 9-11, 2024, with Verrica's session scheduled for September 9 at 1:30 PM ET.
How can I access the live webcast of the conference?
The live webcast can be accessed through Verrica’s official website, with a replay available shortly after the presentation.
What products does Verrica currently offer?
Verrica's notable product is YCANTH (VP-102), which is FDA-approved for treating molluscum contagiosum, along with ongoing developments in warts and skin cancer treatments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Seven Gables Real Estate Partners with Local Logic for Insights
- Experience Romance at Fairmont Orchid Inspired by 'The Bachelorette'
- Binswanger Welcomes Brooke Oldt as Senior VP of Corporate Services
- GlobalVetLink's Automation Tool Enhances Rabies Vaccine Management
- Randstad US Study: Political Conversations and Workplace Safety
- Hackensack Meridian Health Foundation Gala Honors Eli Manning
- Apple's Anticipated 'Glowtime' Event to Unveil Innovations
- Brunswick Corporation Awarded Trustworthy Company Recognition
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Goya Foods Launches GOYA® Cares Hydrate for Hope Campaign
- Winking Studios Unveils GenMotion.AI for 3D Animation Innovation
- Norfolk Southern Signs Tentative Agreements with SMART-TD Unions
- Wells Fargo Advises Investors to Buy Election Weakness
- Blue Circle Health Launches New T1D Program in Northern States
- West Shore Home Appoints Al Patel as New Chief Marketing Officer
- Mid-Atlantic BioTherapeutics and Accelero Unite for Drug Discovery
- Saphyre and WTax Launch Innovative Tax Reclaim Solutions
- Steve Varsano Receives Aviator Award for Lifetime Achievement
- Sanguine Biosciences Achieves ISO Certifications for Quality
- Kuehn Law Investigates Mergers of FBMS, IP, AFBI, CNDA Stocks
- House Doctors Launches Aging in Place Services Nationwide
- Alibaba International Concludes 2024 E-Commerce Challenge
- Biden Administration Lacks Business Experience, New Study Reveals
- TrustGrid Partners with Department of Air Force for Innovation
- African Leaders Forge Pragmatic Ties with Chinese Localities
Recent Articles
- BLADE Enhances Air Travel Experience with Qatar Airways
- King Faisal Hospital Earns C3 Summit Award Nomination!
- Exploring Top Dividend Stocks: Verizon, J&J, and Nike
- Stitch Fix Welcomes Timothy Baxter and Fiona Tan to Board
- Quickplay Enhances OTT Solutions with AWS Marketplace Launch
- Service World Expo 2024: Key Insights and Exciting Trends
- Critical Metals Corp. Launches Drilling at Tanbreez Project
- GMA Consulting Welcomes Industry Veteran Greg Roselli
- GridGain to Showcase Real-Time Data Innovations at Conferences
- Bad Ass Coffee of Hawaii Expands with New Jersey Franchise Deal
- LIXTE Secures U.S. Patent for Innovative Cancer Treatments
- Fortress Biotech's Upcoming Presentation at Global Conference
- MacPaw's CleanMy®Phone Triumphs with Double Design Awards
- EmVenio Research Expands Role as Global Impact Partner
- Capsida Biotherapeutics to Showcase Advancements in Gene Therapy
- RocketReach Unveils Autopilot for Seamless Outreach Automation
- Understanding Why Most Americans Avoid Investing in Stocks
- Conagra Brands Announces First Quarter Earnings Release Date
- Vesalio's pVasc Thrombectomy System Transforms Patient Care
- Amir Dan Rubin to Lead Healthcare Innovation at Summit
- Reviving Traditional Chinese Culture Along the Grand Canal
- Leslie's, Inc. Engages at Goldman Sachs Global Retailing Event
- HARIBO Launches Fall Edition Goldbears and Halloween Treats
- Hormel Foods Releases Impressive Q3 2024 Financial Results
- Subtle Medical Secures Phase II Funding for Brain Imaging Tech